An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar
- PMID: 30621750
- PMCID: PMC6325816
- DOI: 10.1186/s13059-018-1618-7
An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar
Abstract
How viruses evolve within hosts can dictate infection outcomes; however, reconstructing this process is challenging. We evaluate our multiplexed amplicon approach, PrimalSeq, to demonstrate how virus concentration, sequencing coverage, primer mismatches, and replicates influence the accuracy of measuring intrahost virus diversity. We develop an experimental protocol and computational tool, iVar, for using PrimalSeq to measure virus diversity using Illumina and compare the results to Oxford Nanopore sequencing. We demonstrate the utility of PrimalSeq by measuring Zika and West Nile virus diversity from varied sample types and show that the accumulation of genetic diversity is influenced by experimental and biological systems.
Keywords: Amplicon sequencing; Intrahost evolution; SNP calling; Viral sequencing; West Nile; Zika.
Conflict of interest statement
Ethics approval and consent to participate
Research on human subjects was conducted in compliance with existing regulations relating to the protection of human subjects and was evaluated and approved (#IRB-15-6664) by the Institutional Review Board/Ethics Review Committee at The Scripps Research Institute. Clinical samples were obtained from the Florida Department of Health (DOH) and Antibody Systems Inc. Samples collected in Florida were collected under a waiver of consent granted by the Florida DOH Human Research Protection Program. The work received a non-human subjects research designation (category 4 exemption) by the Florida DOH since this research was performed with leftover clinical diagnostic samples involving no more than minimal risk. Hence, written informed consent was not obtained. All samples were de-identified prior to receipt by the study investigators. The experimental methods used comply with the Helsinki Declaration.
Research involving Indian origin rhesus macaques was conducted at the California National Primate Research Center, and experimental infections of mice upon which
Consent for publication
Not applicable.
Competing interests
NJL has received travel and accommodation expenses from Oxford Nanopore Technologies to attend meetings, and an honorarium to speak at an internal company meeting. NJL has previously received free-of-charge reagents and consumables in support of research projects from Oxford Nanopore Technologies. The other authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
Publication types
MeSH terms
Grants and funding
- MR/L015080/1/MRC_/Medical Research Council/United Kingdom
- UL1 TR001114/TR/NCATS NIH HHS/United States
- P51 OD011107/OD/NIH HHS/United States
- R21AI137690/AI/NIAID NIH HHS/United States
- MR/M501621/1/MRC_/Medical Research Council/United Kingdom
- T32 AI007244/AI/NIAID NIH HHS/United States
- R21 AI129479/AI/NIAID NIH HHS/United States
- UL1TR002550/TR/NCATS NIH HHS/United States
- U01 CK000516/CK/NCEZID CDC HHS/United States
- U01CK000516/ACL/ACL HHS/United States
- U19AI135995/AI/NIAID NIH HHS/United States
- MC_PC_15100/MRC_/Medical Research Council/United Kingdom
- HHSN272201400048C/AI/NIAID NIH HHS/United States
- R01 AI099210/AI/NIAID NIH HHS/United States
- U19 AI135995/AI/NIAID NIH HHS/United States
- R21 AI137690/AI/NIAID NIH HHS/United States
- UL1 TR002550/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
